Werewolf Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.14 M | $13.03 M | 0.00% | 14.06% |
| MPM ASSET MANAGEMENT LLC | 11/13/2024 | 4.28 M | $9.08 M | 0.00% | 9.80% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 3.40 M | $7.21 M | 4.86% | 7.78% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.39 M | $5.06 M | 0.00% | 5.46% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.15 M | $4.57 M | 0.29% | 4.93% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.00 M | $4.24 M | 0.00% | 4.58% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.64 M | $3.47 M | 100.00% | 3.75% |
| VANGUARD GROUP INC | 11/13/2024 | 1.42 M | $3.00 M | 6.93% | 3.24% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 1.33 M | $2.83 M | 0.00% | 3.05% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.32 M | $2.81 M | 19.23% | 3.03% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 700,000 | $1.48 M | 0.00% | 1.60% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 685,989 | $1.45 M | 6.31% | 1.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 626,810 | $1.33 M | 0.00% | 1.43% |
| DC FUNDS, LP | 11/14/2024 | 589,102 | $1.25 M | 0.00% | 1.35% |
| STATE STREET CORP | 11/14/2024 | 476,439 | $1.01 M | 12.39% | 1.09% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 265,359 | $561,000 | 24.99% | 0.61% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 257,844 | $546,629 | 60.57% | 0.59% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 256,300 | $543,356 | 7.10% | 0.59% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 235,705 | $499,695 | 0.00% | 0.54% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 180,608 | $382,889 | -17.67% | 0.41% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 152,200 | $322,664 | -10.99% | 0.35% |
| MORGAN STANLEY | 11/14/2024 | 119,040 | $252,365 | 142.88% | 0.27% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 115,141 | $244,099 | 121.05% | 0.26% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 109,816 | $232,810 | -65.63% | 0.25% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 108,968 | $231,012 | 10.69% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 88,086 | $186,742 | -29.58% | 0.20% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 78,842 | $167,145 | 0.00% | 0.18% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 73,370 | $155,545 | 40.97% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 57,928 | $122,807 | -14.36% | 0.13% |
| BARCLAYS PLC | 11/19/2024 | 54,810 | $116,000 | 130.10% | 0.13% |
| EDGEWOOD MANAGEMENT LLC | 11/12/2024 | 50,000 | $106,000 | 0.00% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 41,413 | $87,796 | 10.04% | 0.09% |
| RHUMBLINE ADVISERS | 11/12/2024 | 28,396 | $60,192 | -12.75% | 0.07% |
| SEI INVESTMENTS CO | 11/12/2024 | 21,322 | $45,203 | 100.00% | 0.05% |
| XTX TOPCO LTD | 11/14/2024 | 21,209 | $44,963 | 100.00% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 17,111 | $36,275 | 100.00% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 16,300 | $34,556 | -0.62% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 15,479 | $32,815 | 57.82% | 0.04% |
| JANE STREET GROUP, LLC | 11/15/2024 | 15,149 | $32,116 | -46.99% | 0.03% |
| CERTUITY, LLC | 11/12/2024 | 15,000 | $31,800 | 50.00% | 0.03% |
| REGAL INVESTMENT ADVISORS LLC | 11/12/2024 | 14,459 | $30,654 | 100.00% | 0.03% |
| HBK SORCE ADVISORY LLC | 11/12/2024 | 13,679 | $29,000 | 3.42% | 0.03% |
| INVESCO LTD. | 11/12/2024 | 13,636 | $28,908 | -2.79% | 0.03% |
| SG AMERICAS SECURITIES, LLC | 10/03/2024 | 13,517 | $29,000 | 100.00% | 0.03% |
| JPMORGAN CHASE & CO | 12/26/2024 | 13,320 | $28,238 | 1.87% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 12,846 | $27,234 | 2.88% | 0.03% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 11,777 | $24,967 | 100.00% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 11,507 | $24,395 | -82.01% | 0.03% |
| FINANCIAL PERSPECTIVES, INC | 10/17/2024 | 6,750 | $14,310 | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 5,256 | $11,143 | -77.89% | 0.01% |
Werewolf Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 79 institutional investors and hedge funds held shares of Werewolf Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 6.14 M
MPM ASSET MANAGEMENT LLC: 4.28 M
PFM Health Sciences, LP: 3.4 M
BioImpact Capital LLC: 2.39 M
BANK OF AMERICA CORP /DE/: 2.15 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2 M
73.14% of Werewolf Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.27 M shares in the last 24 months. This purchase volume represents approximately $48.25 M in transactions.